In a presentation called, “FDA Fast Tracks $6.8 Billion Miracle for July 1st Approval,” Jeff Brown disclosed that a firm has been testing an antibiotic that could possibly rid one of COVID-19. Interestingly, this firm was able to skip Phase 2 trials and has now gotten Phase 3 approval. Some of the investors who’ve backed this firm include the U.S. military, Google and Bill Gates.
While Bill Gates has backed a number of firms including Inovio Pharmaceuticals Inc., and Modera Inc. among others – all of whom are working towards a vaccine that is expected to be ready in a year from now, Brown trusts that one firm is surely to rise up. To learn more in regard to this firm, individuals will have to become a member of Exponential Tech Investor.
The purpose of this review is to provide a complete breakdown of Jeff Brown's Exponential Tech Investor, which in turn will give individuals a better picture as to whether this service is suitable for one’s investment needs by getting insider intel directly from one of America's top biotech investors.
Contents
What is Exponential Tech Investor?
Exponential Tech Investor is a financial newsletter run by editor, Jeff Brown. The main goal is to help individuals find investment opportunities that are usually missed by established investors. Rather than picking big companies, Brown appears to focus on tiny, early-stage companies that have upside potential.
Given the new presentation to promote Exponential Tech Investor, Jeff says imminent FDA approval could send this tiny biotech soaring because the Food and Drug Administration is the ultimate gatekeeper in the drug approval process. Here are a few stock pick examples Jeff's team has identified:
- Agios Pharmaceuticals: +740%
- MyoKardia: +884%
- G1 Therapeutics: +442%
- Regenxbio: +894%
- Clovis Oncology: +585%
- Karuna Therapeutics: +629%
- Amarin: +733%
- Agile Therapeutics: +1,086%
So now everyone wants to know what is the next biotech stock that is in line for FDA approval as the governing body fast-tracked the process on the most powerful antibiotic in almost 40 years.
Who is Jeff Brown?
While one might only see Jeff Brown as the editor behind Exponential Tech Investor, there’s a whole story to be told. As per Bonner and Partners, Brown is a high-tech executive with 25 years of experience. Throughout his career as an active angel investor in early stage technology, he’s managed to get himself talking to the biggest names in the industry. This in turn led him to gain access to information that is usually not disclosed to the general public. Currently, he’s the editor of not only Exponential Tech Investor, but also The Near Future Report and Early Stage Trader.
What will I get by becoming a member of Exponential Tech Investor?
By becoming a member of Exponential Tech Investor, individuals will gain insight on Brown’s findings. He claims to share details regarding a new tiny technology stock that is expected to soar. Another area he aims to cover is that of 5G, as it is projected to be worth $667 billion within a couple of years. Simply put, everything can be found in the following reports:
The Miracle Cure: How to Profit from the Next Generation of Antibiotics
According to Brown, the first report contains information on the biotech micro-capitalization technology firm responsible for “one of the biggest antibiotic breakthroughs since 1980.” He predicts that with Phase 3 of the tests due as early as July 1st, the stock disclosed here is likely to soar by 12 times its original value. In addition, he supposedly has access to the exact FDA timeline of this company.
The Pharma Trailblazer: Unlocking The Cures of Tomorrow
The second report reveals details on a firm that carries the necessary technology that could potentially aid in relieving infectious diseases. Their efforts have supposedly paid off in relation to cancer therapies and vaccines.
5G Fortunes: How to Make a Fortune on the Next Tech Revolution
This report covers a 5G firm whose stock is supposedly less than $10. Interestingly, Brown affirms that this company will watch its shares go up by 1000%. On that note, he will not only share his research, but also when the best buy time is and the process of placing an order.
Monthly Issues & Text Alerts
Every month, Brown will share a 20-page briefing that reveals technology breakthroughs worth investing in. To ensure that members get in at the right time, Brown will be sending text alerts on new updates and recommendations.
24/7 Membership Site
This members-only website serves as a backlog to Brown’s research. Everything from his monthly issues to trade alerts and recommendations will be saved and accessible here.
How much does the Exponential Tech Investor Membership cost?
The original price of the Exponential Tech Investor membership is $4000, however, as a limited time offer, Brown is only charging $2000 for two years. In addition, he’s also giving a full, 90 days to review his service. Should this service bring dissatisfaction of any sort, it is a matter of calling customer service at (855) 849-2885 and requesting a refund.
Final Thoughts
Exponential Tech Investor is a financial newsletter that focuses on early-stage tech companies with the potential to bring gains. With Brown’s 25 years of experience, it could be of interest to explore his recommendations and how he goes about picking his recommendations.
As for its price, for two years of service, individuals will only have to pay $2,000. While one might argue that the price is high – especially with some services offered under $100 – Exponential Tech Investor does come with a money-back guarantee. So, if the information shared isn’t as well-rounded as one would have wanted it to be, then it is a matter of requesting a refund.
Based on reviews posted by existing and/or former members of Exponential Tech Insider, there are some good and bad to consider. To start with the good, those in support of Brown argued that he has helped them make profits while incurring some losses (win ratio of 75%) and provided satisfying analyses. On the other hand, those who found issues with the service revealed that Brown has the tendency to underline the highly performing stocks while brushing away the losses, found the membership to be overpriced, and that he was late to suggest entry points.
Ultimately, individuals are suggested to conduct their respective research and consult customer service regarding any concerns prior to investing, as current reviews seem to tell two different stories.
To learn more about Exponential Tech Investor, click here.
